Related Experiment Video
Updated: Jun 7, 2026

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
Posttranscriptional regulation of PTEN dosage by noncoding RNAs
1Division of Cellular and Developmental Biology, Molecular and Cellular Biology Department, University of California at Berkeley, Berkeley, CA 94705, USA. lhe@berkeley.edu
Abstract:
The classic "two-hit" model of tumor-suppressor inactivation, originally established by mathematical modeling of cancer incidence, implies that tumorigenesis requires complete loss of function of tumor-suppressor genes. Although this is true in some tumor types, the exact nature of tumor-suppressor deregulation varies depending on tissue type, stage of cancer development, nature of coexisting molecular lesions, and environmental factors. Emerging evidence has indicated the functional importance of PTEN (phosphatase and tensin homolog) dosage during tumor development. Among the key regulators of PTEN dosage are a number of noncoding RNAs, including microRNAs (miRNAs) and pseudogenes, which regulate PTEN abundance at the posttranscriptional level. Various studies have revealed the essential roles of these PTEN-targeting noncoding RNAs during tumor development, thus providing a paradigm to explore the molecular mechanisms underlying the dosage-dependent effects of key oncogenes and tumor suppressors.
Insights
Tumor suppressor gene inactivation is complex. PTEN dosage, regulated by noncoding RNAs like miRNAs, is crucial for tumor development, offering new insights into cancer mechanisms.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The traditional "two-hit" model suggests complete tumor-suppressor gene loss for tumorigenesis.
- Tumor-suppressor deregulation is complex and varies by cancer type, stage, and other factors.
- Emerging evidence highlights the critical role of PTEN (phosphatase and tensin homolog) gene dosage in tumor development.
Purpose of the Study:
- To explore the role of PTEN dosage in tumorigenesis.
- To investigate how noncoding RNAs regulate PTEN abundance.
- To understand the molecular mechanisms of dosage-dependent effects in cancer.
Main Methods:
- Review of existing studies on tumor-suppressor genes, PTEN, and noncoding RNAs.
- Analysis of posttranscriptional regulation mechanisms.
- Exploration of PTEN-targeting noncoding RNAs, including microRNAs (miRNAs) and pseudogenes.
Main Results:
- PTEN dosage is functionally important in tumor development.
- Noncoding RNAs, such as miRNAs and pseudogenes, are key regulators of PTEN abundance.
- These PTEN-targeting noncoding RNAs play essential roles in tumor progression.
Conclusions:
- Tumorigenesis is not solely dependent on complete loss of tumor-suppressor function.
- PTEN dosage regulation by noncoding RNAs provides a paradigm for understanding oncogene and tumor-suppressor dosage effects.
- Further research into these mechanisms can reveal new therapeutic targets.
Related Concept Videos
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
What is Gene Expression?
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...